enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Sucralfate - Wikipedia

   en.wikipedia.org/wiki/Sucralfate

   Sucralfate, sold under various brand names, is a medication used to treat stomach ulcers, gastroesophageal reflux disease (GERD), radiation proctitis, and stomach inflammation and to prevent stress ulcers. [3][4][5] Its usefulness in people infected by H. pylori is limited. [3] It is used by mouth (for upper GIT ulcers) and rectally (for ...

3. Omeprazole - Wikipedia

   en.wikipedia.org/wiki/Omeprazole

   Omeprazole is a proton-pump inhibitor (PPI) and its effectiveness is similar to that of other PPIs. [9] It can be taken by mouth or by injection into a vein. [1][10] It is also available in the fixed-dose combination medication omeprazole/sodium bicarbonate as Zegerid [11][12] and as Konvomep. [13]

4. Ranitidine - Wikipedia

   en.wikipedia.org/wiki/Ranitidine

   Ranitidine. Ranitidine, previously sold under the brand name Zantac[a] among others, is a medication used to decrease stomach acid production. [12] It was commonly used in treatment of peptic ulcer disease, gastroesophageal reflux disease, and Zollinger–Ellison syndrome. [12]

5. FDA orders all Zantac heartburn products off store shelves

   www.aol.com/news/2020-04-01-fda-orders-all...

   All Zantac products and generic versions of the heartburn medication should be taken off pharmacy shelves immediately, the Food and Drug Administration announced Wednesday.

6. Famotidine - Wikipedia

   en.wikipedia.org/wiki/Famotidine

   Famotidine. Famotidine, sold under the brand name Pepcid among others, is a histamine H 2 receptor antagonist medication that decreases stomach acid production. [4] It is used to treat peptic ulcer disease, gastroesophageal reflux disease, and Zollinger-Ellison syndrome. [4] It is taken by mouth or by injection into a vein. [4]

7. FDA Approves New GERD Treatment Vonoprazan for ... - AOL

   www.aol.com/fda-approves-gerd-treatment...

   On July 18, the Food and Drug Administration approved Phathom Pharmaceuticals’ medication vonoprazan (Voquezna) as a daily treatment for heartburn associated with non-erosive gastroesophageal ...